Aspergillosis Drug Industry Competitive Landscape and Strategic Evolution The Aspergillosis Drug Market was valued at USD 1.42 billion in 2024 and is projected to reach USD 2.78 billion by 2034, registering a CAGR of 6.9%. This growth trajectory reflects the escalating global burden of fungal infections, particularly among immunocompromised populations and critically ill patients requiring intensive care management. Click to access the Report Study, read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/aspergillosis-drug-market